Patients diagnosed with COVID-19 are reported to have high levels of interleukin (IL)1β, interferon (IFN)γ, interferon-inducible protein 10 (IP10), and monocyte chemoattractant protein 1 (MCP1), likely leading to activated T helper-1 cell responses. The gene discussed is CCL2; the disease is COVID-19.